高乐士公司（NYSE:CLX）第二季度的盈利和收入超出了预期，但其净销售额同比下降了15%。管理层重申了对第四季度预测的信心，预计有机销售将实现中到高个位数的增长，得益于企业资源计划（ERP）的实施。 事件背景：ERP是高乐士公司正在实施的一项软件系统升级，用于现代化其核心业务流程，包括供应链、财务和其他运营领域。过渡预计将在六个月内分阶段完成。 在财报电话会议上，公司CEO琳达·兰德尔表示：“ERP过渡是我们数字化转型中非常重要的一步，继续确保我们拥有数据，并以正确的速度和能力推动增长和生产力。” 虽然公司指导其第三季度有机销售将实现低个位数增长，受剥离业务和外汇的影响，CFO凯文·雅各布森表示：“ERP过渡将在全年增加1到2个百分点的增长，全部将在第四季度实现。” 重要性：高乐士超出分析师预期，报告收入为16.9亿美元，调整后的每股收益为$1.55。尽管净销售额同比下降了15%，公司提高了毛利率至43.8%，并将运营现金流增加到4.01亿美元。 高乐士预计在ERP影响之前，自由现金流目标的11-13%销售百分比的较高端，ERP实施可能会因库存增加和预付供应商而使其接近区间的低端。 股价变动：高乐士股价上涨0.69%，周一收于$159.78。追踪标普500指数的交易所交易基金SPDR S&P 500 ETF Trust（NYSE:SPY）在周一下跌了0.67%，收于$597.77。 根据Benzinga追踪的22位分析师的平均目标价为$151.4，评级为“卖出”，估值范围从$120到$187。RBC Capital、巴克莱和摩根大通的最新评级建议的目标价为$150.33，暗示潜在下跌幅度为3.34%。

以上内容来自Benzinga Earnings专栏，原文如下：

Clorox Co.’s (NYSE:CLX) second-quarter earnings and revenue exceeded expectations, however, its net sales declined 15% annually. The management reinstated confidence in its fourth-quarter forecast expecting mid-to-high-single-digit growth in organic sales driven by the Enterprise Resource Planning (ERP) implementation.

What Happened: ERP refers to a software system upgrade that Clorox is implementing to modernize its core business processes, including supply chain, finance, and other operational areas. The transition is expected to be completed in phases over six months.

During its earnings call the company CEO Linda Rendle said, “ERP transition is a very important step in our digital transformation, continuing to ensure that we have data and can move at the right speed with the right capabilities to enable the growth and productivity that we’re driving.”

While the company guided its third-quarter organic sales to be up low-single digits, with an impact from divestitures and forex, CFO Kevin Jacobsen said, “The ERP transition will add 1 to 2 points of growth over the course of the year, it’s all going to happen in Q4.”

See Also: Illumina Stock Tumbles Nearly 5% Overnight On Robinhood As China Adds ILMN, Calvin Klein Owner PVH To ‘Unreliable Entities List’ Amid Trade War With US

Why It Matters: Clorox exceeded analysts’ expectations, reporting revenue of $1.69 billion and adjusted earnings of $1.55 per share. Despite a 15% decline in year-over-year net sales, the company improved its gross margin to 43.8% and increased operating cash flow to $401 million.

Clorox anticipates being at the higher end of its 11-13% free cash flow target as a percentage of sales before the ERP impact. The ERP implementation will likely bring it closer to the low end of the range due to inventory build and pre-paying suppliers.

Price Action: Shares of Clorox rose 0.69% to end Monday at $159.78 apiece. The exchange-traded fund tracking the S&P 500 index, SPDR S&P 500 ETF Trust (NYSE:SPY) declined 0.67% to $597.77 on Monday.

The average price target among 22 analysts tracked by Benzinga is $151.4 with a ‘sell' rating. The estimates range from $120 to $187 apiece. Recent ratings from RBC Capital, Barclays, and JP Morgan suggest a $150.33 target, implying a potential downside of 3.34%.

Read Next:

• Winner Winner, Chicken Dinner: Tyson Foods Q1 Beat Showcases ‘Improved Execution' In Poultry, Says CEO

Photo courtesy: Shutterstock